AVE 0.00% 0.2¢ avecho biotechnology limited

financials are out , page-2

  1. 379 Posts.
    Very terse statement. Does highlight the disaster that has been Elixia & why complete restart has been necessary. Admission that its failure has been a contributor to loss, and consequently a drain on scarce funds.

    However, with the tax rebates they clearly have sufficient funds to see the main programme through (provided, of course, they can restrain themselves on vanity projects...??).

 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.